A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

Clinical trial NCT05683418 · RECRUITING

Trial details

NCT number: NCT05683418
Sponsor: Totus Medicines
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HR+/HER2-negative Breast Cancer

Start date: 2023-02-15
Primary completion: 2027-12-01
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.